Original Title: Impact of the Right Atrial Pressure on Fractional Flow Reserve Measurements Comparison of Fractional flow Reserve and Myocardial Fractional flow Reserve in 1600 Coronary Stenosis. Reference: Toth G, et al. JACC Cardiovasc Interv. 2016 Feb 12. Epub ahead of print. Courtesy of Dr. Guillermo Migliaro. Fractional Flow Reserve (FFR) is the gold standard for the<a href="https://solaci.org/en/2016/02/29/impact-of-the-right-atrial-pressure-on-ffr-measurement/" title="Read more" >...</a>
Original title: Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial. Reference: Francesco Liistro et al. Am Heart J 2013;166:920-6. Recently, drug eluting balloons (DEB) have emerged as a potential alternative to drug-eluting stents (DES). Paclitaxel is an appropriate drug for DEBs given<a href="https://solaci.org/en/2013/12/03/drug-eluting-balloon-followed-bms-versus-des-in-de-novo-lesions/" title="Read more" >...</a>
Original title: Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Reference: Li J et al. Eur Heart J. 2013; Epub ahead of print Precision of the fractional flow reserve (FFR) to estimate the functional compromise of coronary stenosis and its ability to reduce events to decide PTCA, based on their outcome has<a href="https://solaci.org/en/2013/02/06/the-ffr-improves-outcomes-in-daily-practice-as-in-randomized-studies/" title="Read more" >...</a>
Discover all the live national and international cases at the upcoming SOLACI-CACI 2024 Congress.
Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in women and patients with renal insufficiency. This phenomenon is characterized by an increase in valvular annulus fibrosis, which can extend and affect the leaflets. The presence of MAC is associated with valve regurgitation or stenosis, increasing mortality and<a href="https://solaci.org/en/2024/07/18/myocardial-damage-in-mac/" title="Read more" >...</a>
Timely percutaneous intervention of STEMI patients effectively reduces MI size and mortality, which currently makes it the first line of treatment. A fundamental aspect is activation and platelet aggregation, which is why, in addition to creating networks to optimize STEMI treatment, prehospital drug treatments have been implemented. The COMPARECrush looked at whether early and powerful<a href="https://solaci.org/en/2024/07/08/prehospital-crushed-vs-integral-prasugrel-in-stemi-patients-with-large-myocardial-area-at-risk/" title="Read more" >...</a>
Untreated tricuspid regurgitation (TR) has been associated to high morbimortality. Surgical treatment of isolated severe TR is complex and carries a high mortality rate. A transcatheter treatment of this valve is currently being developed, and different concepts are being applied to the new devices. Even though most TR is secondary, atrial functional tricuspid regurgitation (A-FTR)<a href="https://solaci.org/en/2024/07/04/cardioband-in-tricuspid-valve-regurgitation/" title="Read more" >...</a>
When deciding on the optimal coronary artery revascularization treatment of coronary artery disease (CAD) patients, physicians normally assessed clinical presentation, surgical risk, survival expectation, and the likelihood of a better quality of life. Decisions are made after careful consideration, by the Heart Team, who will ponder options such as coronary artery bypass graft (CABG), percutaneous<a href="https://solaci.org/en/2024/06/26/events-in-cad-patients-who-refused-or-were-ineligible-for-cabg/" title="Read more" >...</a>
Multiple studies support the use of an early invasive approach in high risk patients with non-ST elevation acute coronary syndrome (NST ACS). This benefit of an invasive strategy over the expected management has been shown in randomized studies and meta-analysis. Patients with a history of cardiac artery bypass graft (CABG) represent approximately 10% of ACS<a href="https://solaci.org/en/2024/06/10/patients-with-cabg-history-and-new-n-st-acs-routine-invasive-strategy/" title="Read more" >...</a>
Complete revascularization has shown in several studies and meta-analysis a benefit in mortality vs. incomplete revascularization. The REVIVED-BCIS looked at whether there were differences in mortality and hospitalization for cardiac failure in patients with ventricular function deterioration and viability when comparing coronary angioplasty(PCI) against optimal medical treatment. This study showed that PCI was not associated<a href="https://solaci.org/en/2024/05/17/europcr-2024-complete-revascularization-affects-clinical-outcomes-revived-bcis2-insights/" title="Read more" >...</a>